A study on the position and etiology of infection in cirrhotic patients: A potential precipitating factor contributing to hepatic encephalopathy

Experimental and Therapeutic Medicine

Volumn 6, Issue 2, 2013, Pages 584-590

  Wang, Qiu Ming ^a   Ji, Qing ^b   Duan, Zhi Jun ^a   Zhang, Ming ^c   Chang, Qing Yong ^d  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b Department of Gastroenterology   (China)

^c XI'AN MEDICAL UNIVERSITY   (China)

^d DALIAN UNIVERSITY   (China)

Author keywords

Hepatic encephalopathy; Infection; Precipitating factors

Indexed keywords

ADULT; AGED; AMMONIA BLOOD LEVEL; ARTICLE; BACTERIAL INFECTION; DIGESTIVE SYSTEM INFECTION; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LEUKOCYTE COUNT; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PERITONEAL AND RETROPERITONEAL INFECTIONS; PNEUMOCOCCAL INFECTION; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; UROGENITAL TRACT INFECTION;

EID: 84879616012     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1137     Document Type: Article

References (42)

1. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K and Blei AT: Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35: 716-721, 2002.
2. Zhang FK, Zhang JY and Jia JD: Treatment of patients with alcoholic liver disease. Hepatobiliary Pancreat Dis Int 4: 12-17, 2005.
3. Häussinger D: Hepatic encephalopathy. Acta Gastroenterol Belg 73: 457-464, 2010.
4. Shawcross DL, Sharifi Y, Canavan JB, et al: Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis. J Hepatol 54: 640-649, 2011.
5. Bustamante J, Rimola A, Ventura PJ, et al: Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 30: 890-895, 1999.
6. Bellot P, Jara Pérez López N, Martínez Moreno B and Such J: Current problems in the prevention and treatment of infections in patients with cirrhosis. Gastroenterol Hepatol 33: 729-740, 2010 (In Spanish).
7. Zhuang J: 52 cases analysis of precipitating factors in cirrhosis with hepatic encephalopathy. J Clin Hepatol 10: 57-58, 2007 (In Chinese).
8. Zhang M and Duan ZJ: Retrospective analysis of factors influencing the development and progression of hepatic encephalopathy in patients with hepatitis B virus related cirrhosis. Shi Jie Hua Ren Xiao Hua Za Zhi 20: 1148-1155, 2012 (In Chinese).
9. O'Shea RS, Dasarathy S, McCullough AJ, et al; Practice Guideline Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology: Alcoholic liver disease. Hepatology 51: 307-328, 2010.
10. Papadopoulos N, Soultati A, Goritsas C, et al: Nitric oxide, ammonia, and CRP levels in cirrhotic patients with hepatic encephalopathy: is there a connection? J Clin Gastroenterol 44: 713-719, 2010.
11. Devrajani BR, Shah SZ, Devrajani T and Kumar D: Precipitating factors of hepatic encephalopathy at a tertiary care hospital Jamshoro, Hyderabad. J Pak Med Assoc 59: 683-686, 2009.
12. McAvoy HC and Hayes PC: Hepatic encephalopathy. Medicine 35: 108-111, 2006.
13. Häussinger D and Görg B: Interaction of oxidative stress, astrocyte swelling and cerebral ammonia toxicity. Curr Opin Clin Nutr Metab Care 13: 87-92, 2010.
14. Atluri DK, Prakash R and Mullen KD: Pathogenesis, diagnosis, and treatment of hepatic encephalopathy. J Clin Exp Hepatol 1: 77-86, 2011.
15. Vaquero J, Polson J, Chung C, et al: Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology 125: 755-764, 2003.
16. Licinio J and Wong ML: Pathways and mechanisms for cytokine signaling of the central nervous system. J Clin Invest 100: 2941-2947, 1997.
17. Bémeur C, Desjardins P and Butterworth RF: Antioxidant and anti-inflammatory effects of mild hypothermia in the attenuation of liver injury due to azoxymethane toxicity in the mouse. Metab Brain Dis 25: 23-29, 2010.
18. Cauli O, Rodrigo R, Piedrafita B, Llansola M, Mansouri MT and Felipo V: Neuroinflammation contributes to hypokinesia in rats with hepatic encephalopathy: ibuprofen restores its motor activity. J Neurosci Res 87: 1369-1374, 2009.
19. Rodrigo R, Cauli O, Gomez-Pinedo U, et al: Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy. Gastroenterology 139: 675-684, 2010.
20. Karvellas CJ, Pink F, McPhail M, et al: Bacteremia, acute physiology and chronic health evaluation II and modified end stage liver disease are independent predictors of mortality in critically ill nontransplanted patients with acute-on-chronic liver failure. Crit Care Med 38: 121-126, 2010.
21. Shawcross DL, Olde Damink SW, Butterworth RF and Jalan R: Ammonia and hepatic encephalopathy: the more things change, the more they remain the same. Metab Brain Dis 20: 169-179, 2005.
22. Cauli O, Rodrigo R, Piedrafita B, Boix J and Felipo V: Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts. Hepatology 46: 514-519, 2007.
23. Shawcross DL, Davies NA, Williams R and Jalan R: Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 40: 247-254, 2004.
24. Blei AT: Infection, inflammation and hepatic encephalopathy, synergism redefined. J Hepatol 40: 327-330, 2004.
25. Shawcross DL, Wright G, Olde Damink SW and Jalan R: Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab Brain Dis 22: 125-138, 2007.
26. Sharifi Y, Canavan JB, Yeoman AD, et al: Defining the outcome, precipitants and cost of severe hepatic encephalopathy (HE) in cirrhosis. Hepatology 48 (Suppl): 1061A, 2008.
27. Shawcross DL, Shabbir SS, Taylor NJ and Hughes RD: Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology 51: 1062-1069, 2010.
28. Shawcross DL, Wright GA, Stadlbauer V, et al: Ammonia impairs neutrophil phagocytic function in liver disease. Hepatology 48: 1202-1212, 2008.
29. Wasmuth HE, Kunz D, Yagmur E, et al: Patients with acute-on-chronic liver failure display 'sepsis-like' immune paralysis. J Hepatol 42: 195-201, 2005.
30. Antoniades CG, Wendon J and Vergani D: Paralysed monocytes in acute-on-chronic liver disease. J Hepatol 42: 163-165, 2005.
31. Lin CY, Tsai IF, Ho YP, et al: Endotoxemia contributes to the immune paralysis in patients with cirrhosis. J Hepatol 46: 816-826, 2007.
32. Rosa H, Silvério AO, Perini RF and Arruda CB: Bacterial infection in cirrhotic patients and its relationship with alcohol. Am J Gastroenterol 95: 1290-1293, 2000.
33. Borzio M, Salerno F, Piantoni L, et al: Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis 33: 41-48, 2001.
34. Wiest R and Rath HC: Gastrointestinal disorders of the critically ill. Bacterial translocation in the gut. Best Pract Res Clin Gastroenterol 17: 397-425, 2003.
35. Andreu M, Sola R, Sitges-Serra A, et al: Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites. Gastroenterology 104: 1133-1138, 1993.
36. Bernardi M: Spontaneous bacterial peritonitis: from pathophysiology to prevention. Intern Emerg Med 5 (Suppl 1): S37-S44, 2010.
37. Sigal SH: Hyponatremia in cirrhosis. J Hosp Med 7 (Suppl 4): S14-S17, 2012.
38. Angeli P, Wong F, Watson H and Ginès P; CAPPS Investigators: Hyponatremia in cirrhosis: Results of a patient population survey. Hepatology 44: 1535-1542, 2006.
39. Häussinger D and Schliess F: Pathogenetic mechanisms of hepatic encephalopathy. Gut 57: 1156-1165, 2008.
40. Amodio P, Del Piccolo F, Pettenò E, et al: Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. J Hepatol 35: 37-45, 2001.
41. Baccaro ME, Guevara M, Torre A, Arcos E, Martin-Llahí M, Terra C, Gómez-Anson B, Rami L, Arroyo V and Ginès P: Hyponatremia predisposes to hepatic encephalopathy in patients with cirrhosis. Results of a prospective study with time-dependent analysis. Hepatology 44 (Suppl 1): 233A, 2006.
42. Fernández J, Navasa M, Gómez J, et al: Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 35: 140-148, 2002.